Skip to main content
. 2022 Mar 31;11(2):283–296. doi: 10.1007/s40119-022-00262-w

Table 2.

Matched baseline characteristics of sample population

Characteristic TAVR (ESS = 800) SAVR-SA (ESS = 1426) Total (ESS = 2075) SMD
Age, mean (SD) 79.3 (7.4) 77.9 (7.2) 78.6 (7.3) 0.19
Male, SOW (% weight) 411 (51.4) 1053 (73.8) 1229 (59.2) 0.06
Preoperative comorbidities, mean (SD)
 CHA2DS2-VASC score 3.3 (1.0) 3.2 (1.0) 3.2 (1.0) 0.13
 HAS-BLED score 1.9 (0.5) 1.9 (0.5) 1.9 (0.5) 0.01
Preoperative comorbidities, SOW (% weight)
 Coagulopathy 68 (8.5) 182 (12.8) 205 (9.9) − 0.01
 Depression 62 (7.7) 142 (10.0) 176 (8.5) − 0.01
 Deficiency anemia 37 (4.6) 25 (1.7) 60 (2.9) 0.03
 Diabetes, uncomplicated 236 (29.4) 479 (33.6) 639 (30.8) 0.00
 Fluid and electrolyte disorders 68 (8.4) 152 (10.7) 179 (8.6) 0.05
 Hypertension, uncomplicated 683 (85.3) 1082 (75.9) 1690 (81.5) 0.00
 Hypothyroidism 177 (22.2) 218 (15.3) 389 (18.7) 0.05
 Other neurological disorders 38 (4.8) 55 (3.9) 89 (4.3) 0.02
 Obesity 116 (14.5) 483 (33.9) 406 (19.6) − 0.05
 Pulmonary circulation disorders 92 (11.5) 208 (14.6) 242 (11.7) 0.06
 Peripheral vascular disorders 157 (19.7) 195 (13.7) 352 (17.0) − 0.09
 Rheumatoid arthritis/collagen vascular 48 (6.0) 70 (4.9) 113 (5.4) 0.02
 Peptic ulcer disease excluding bleeding 8 (1.0) 14 (1.0) 20 (0.9) 0.01
 Weight loss 4 (0.5) 7 (0.5) 11 (0.5) − 0.02

ESS effective sample size, SMD standardized mean difference, SD standard deviation, SOW sum of weights